Evidence map›Paper›PMID 26852227›Full record

ArticleMalaria journal2016

Community perceptions of mass screening and treatment for malaria in Siaya County, western Kenya.

Kathryn Shuford, Florence Were, Norbert Awino, Aaron Samuels, Peter Ouma, Simon Kariuki, Meghna Desai, Denise Roth Allen

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Malaria journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02987270 (Evaluation of Community-based Screening and Treatment for Malaria in the KEMRI/CDC Health and Demographic Surveillance System), which is not on this map. Cited by 16 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 3 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02987270 phase3completednot on this map

Evaluation of Community-based Screening and Treatment for Malaria in the KEMRI/CDC Health and Demographic Surveillance System (HDSS) in Western Kenya

TypeinterventionalSponsorSimon KariukiRan2013 to 2015Enrolled90,000ConditionsMalaria,FalciparumArmsDihydroartemisinin-piperaquine
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 3 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Knowledge about Asymptomatic Malaria and Acceptability of UsingInternational journal of environmental research and public health · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Kathryn ShufordCenters for Disease Control and Prevention (CDC), Atlanta, GA, USA. kvshuford@gmail.com.
Florence WereKenya Medical Research Institute (KEMRI), Kisian, Kenya. fachieng@kemricdc.org.
Norbert AwinoKenya Medical Research Institute (KEMRI), Kisian, Kenya. nobatisland@gmail.com.
Aaron SamuelsCenters for Disease Control and Prevention (CDC), Atlanta, GA, USA. amsamuels@cdc.gov.
Peter OumaKenya Medical Research Institute (KEMRI), Kisian, Kenya. pouma@kemricdc.org.
Simon KariukiKenya Medical Research Institute (KEMRI), Kisian, Kenya. skariuki@kemricdc.org.
Meghna DesaiCenters for Disease Control and Prevention (CDC), Atlanta, GA, USA. mdesai@cdc.gov.
Denise Roth AllenCenters for Disease Control and Prevention (CDC), Atlanta, GA, USA. drothallen@cdc.gov.
Centers for Disease Control and Prevention · USKenya Medical Research Institute · KE

Funding

CGH CDC HHS U01 GH000048
6 · The paper itself

Abstract

backgroundIntermittent mass screening and treatment (iMSaT) is currently being evaluated as a possible additional tool for malaria control and prevention in western Kenya. The literature identifying success and/or barriers to drug trial compliance and acceptability on malaria treatment and control interventions is considerable, especially as it relates to specific target groups, such as school-aged children and pregnant women, but there is a lack of such studies for mass screening and treatment and mass drug administration in the general population.

methodsA qualitative study was conducted to explore community perceptions of the iMSaT intervention, and specifically of testing and treatment in the absence of symptoms, before and after implementation in order to identify aspects of iMSaT that should be improved in future rounds. Two rounds of qualitative data collection were completed in six randomly selected study communities: a total of 36 focus group discussions (FGDs) with men, women, and opinion leaders, and 12 individual or small group interviews with community health workers. All interviews were conducted in the local dialect Dholuo, digitally recorded, and transcribed into English. English transcripts were imported into the qualitative software programme NVivo8 for content analysis.

resultsThere were mixed opinions of the intervention. In the pre-implementation round, respondents were generally positive and willing to participate in the upcoming study. However, there were concerns about testing in the absence of symptoms including fear of covert HIV testing and issues around blood sampling. There were fewer concerns about treatment, mostly because of the simpler dosing regimen of the study drug (dihydroartemisinin-piperaquine) compared to the current first-line treatment (artemether-lumefantrine). After the first implementation round, there was a clear shift in perceptions with less common concerns overall, although some of the same issues around testing and general misconceptions about research remained.

conclusionsAlthough iMSaT was generally accepted throughout the community, proper sensitization activities-and arguably, a more long-term approach to community engagement-are necessary for dispelling fears, clarifying misconceptions, and educating communities on the consequences of asymptomatic malaria.

Indexed as

AntimalarialsArtemisininsFemaleHealth Knowledge, Attitudes, PracticeHumansKenyaMalariaMaleMass ScreeningAntimalarialsArtemisininsartenimol

Identifiers

PMID26852227
PMCPMC4744419
OpenAlexW2256281783

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.